glp-1 coverage news Paving the way for expanded | Insights & Events A Bridge to Nowhere? Medicare's

Conclusion: This review synthesizes current evidence on the safety and effectiveness of GLP-1RAs in weight management and potential cardiovascular protection

We have reviewed the metabolic effects of these drugs in relation to improvement of diabetic hyperglycaemia and fatty liver disease, as well as peripheral metabolism and insulin resistance

Related News No related news.

Learn the most common and serious GLP-1 side effects, including nausea, constipation, pancreatitis risk, and when to seek medical attention.

### Competing Interest Statement ASK, AMM, MCG, JMD, CB, CL, SWB, DJL, PML, DRD, JMC, JPF, YL, ARS, DAT, DWP, SH, RBR, MSL, and DAG are employees and stockholders of Pfizer Inc